drugset / Trial / NCT06680440
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of ASC30 Tablets and ASC30 Tablets A1 in Participants With Obesity
RandomizedSequentialQuadruple-blindTreatment
Summary
This is a phase I, randomized, double-blind, placebo-controlled, single and multiple ascending dose study to evaluate the safety, tolerability, pharmacokinetics, efficacy, food effect of ASC30 Tablets or ASC30 Tablets A1 in participants with obesity.
Timeline
- Start
- 2024-08-26
- Primary completion
- 2025-04-03
- Completion
- 2025-04-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ASC30 | Unknown | — | — |
Indications
No indication recorded.